Hyperactive Tn5 Transposase Barcoding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA sequencing library preparation methods using hyperactive Tn5 transposase for fragmentation and barcoding face inefficiencies due to low activity of wild-type end sequences and require additional mutations for enhanced activity, which complicates the process and reduces the reliability of DNA fragmentation and barcoding.

Innovation Solution

The method involves using a transposase loaded with oligonucleotide adaptors comprising a 3' single-stranded portion and a double-stranded portion, introducing double-stranded breaks into DNA, and ligating these adaptors to form barcoded DNA fragments, which are then amplified using PCR, allowing for efficient barcoding and sequencing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If wild-type end sequences are used in Tn5 transposase, then the structure is simple and natural, but the transposition activity is low

Engineering Contradiction:
Improvetransposition activityVSAvoidtransposase structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by modifying the end sequences of the Tn5 transposase from wild-type to hyperactive variants. This involves changing specific nucleotide sequences and amino acid residues to enhance transposition activity. The hyperactive end sequences contain specific mutations that increase the catalytic efficiency of the transposase, resolving the contradiction between maintaining simple structure and achieving high reliability in transposition activity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by creating a hybrid transposase structure that combines elements from different Tn5 variants. The composite end sequences integrate functional domains from multiple sources to achieve both structural integrity and enhanced activity. This composite approach allows the transposase to maintain its fundamental structure while incorporating high-activity regions, thus resolving the contradiction between simplicity and reliability.

Inventive Principle:
Principle #40Composite materials

2Productivity

If hyperactive Tn5 transposase with multiple mutations is used, then transposition activity is enhanced, but the process complexity increases

Engineering Contradiction:
ImproveDNA fragmentation efficiencyVSAvoidtransposase mutation complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent systematically changes parameters of the transposase by introducing specific point mutations at defined positions. Rather than random mutagenesis, the invention identifies critical residues and applies targeted amino acid substitutions that collectively enhance activity. This parameter-based approach optimizes DNA fragmentation efficiency while controlling the complexity of modifications required.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies segmentation by dividing the transposase structure into functional domains and optimizing them independently. The end sequences are treated as separate modular units that can be engineered and assembled. This segmentation allows systematic improvement of fragmentation efficiency through focused modifications of specific regions rather than requiring comprehensive changes throughout the entire protein structure.

Inventive Principle:
Principle #1Segmentation

3Reliability

If additional mutations are introduced to enhance transposase activity, then fragmentation reliability improves, but the risk of unintended effects increases

Engineering Contradiction:
ImproveDNA barcoding reliabilityVSAvoidunintended mutational effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies controlled parameter changes by making specific, well-defined mutations at predetermined positions in the transposase sequence. Each mutation is selected based on its individual contribution to activity enhancement. This precise parameter control allows the invention to improve barcoding reliability while minimizing the risk of unintended effects, as opposed to using broadly mutated or randomly modified transposases.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses the hyperactive end sequences as intermediaries that mediate between the transposase core and the DNA substrate. These engineered end sequences act as buffered interfaces that enhance activity while isolating the core transposase from potential harmful interactions. The intermediary end sequences absorb and direct the effects of mutations, protecting the overall system from unintended consequences.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the efficiency of DNA fragmentation and barcoding by improving the activity of the transposase, resulting in higher-quality DNA fragments suitable for sequencing while maintaining contiguity and allowing for the use of harsh reagents in droplet formation, improving reaction sensitivity.

Implementation Method 1

Transposition is a very infrequent event in vivo, and hyperactive mutants were historically derived by introducing three missense mutations in the 476 residues of the Tn5 protein

Methodology Applied
Scientific EffectTransposition:

Implementation Method 2

the transposase introduces double-stranded breaks into the DNA, wherein each double-stranded break forms two DNA ends and the transposase ligates the first oligonucleotide to one strand of each DNA end

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

hybridizing the 3' end of the first oligonucleotide primer (which is optionally released from the bead) to the 3' single stranded portion of the oligonucleotide adaptor

Methodology Applied
Scientific EffectHybridization:

Implementation Method 4

contacting the reaction mixture with a ligase, thereby ligating the first oligonucleotide primer to the 5' end of the first oligonucleotide ligated to the DNA ends

Methodology Applied
Scientific EffectLigation:

Implementation Method 5

the amplifying comprises polymerase chain reaction

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS20240158847A1Transposase-based genomic analysis
Publication Date: 2024.05.16 BIO RAD LABORATORIES INC
  • US20240158847A1 patent drawing
  • US20240158847A1 patent drawing
  • US20240158847A1 patent drawing

AI summary

The methods and reagents are provided for barcoding and analysis of DNA samples using partition (e.g., droplet) technology while avoiding performing amplification in droplets.